TGFB1 and cancer: Collectively, these results demonstrate that EHMT2-mediated TGF-β1 upregulation in an autocrine manner, inhibits NKG2D ligands (MICB and ULBP3) on cancer cells and, in a paracrine manner, suppresses the cytotoxic ability of NK cells and their migration.